These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3542530)

  • 1. Sensitivity testing with ketoconazole in an assay containing Candida albicans, human polymorphonuclear leukocytes and serum.
    Bauer TM; Kronsteiner W; Bassler M; Daschner FD
    Eur J Clin Microbiol; 1986 Dec; 5(6):665-8. PubMed ID: 3542530
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing.
    Le Moli S; Seminara R; D'Amelio R; Pontesilli O; Nisini R
    Boll Ist Sieroter Milan; 1983; 62(6):531-4. PubMed ID: 6329246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Candida albicans pretreated with ketoconazole and 5-fluorocytosine to fungicidal activity of leukocytes and serum.
    Chiu ML; Minguez F; Lima JF; Garcia MT; Salazar EF; Prieto J
    J Chemother; 1995 Nov; 7 Suppl 4():21-2. PubMed ID: 8904093
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans].
    Korting HC; Schlaf-Maier U; Schäfer-Korting M
    Mykosen; 1986 Jul; 29(7):297-305. PubMed ID: 3528846
    [No Abstract]   [Full Text] [Related]  

  • 8. [The correlation between biotype and antifungal sensitivity of Candida albicans].
    Korting HC; Dorsch R
    Mykosen; 1987 Nov; 30(11):512-9. PubMed ID: 3328045
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.
    Hughes CE; Peterson LR; Beggs WH; Gerding DN
    J Antimicrob Chemother; 1986 Jul; 18(1):65-72. PubMed ID: 3531144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Sep; 43(9):1018-9. PubMed ID: 8240451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broth dilution testing of Candida albicans susceptibility to ketoconazole.
    Hughes CE; Bennett RL; Beggs WH
    Antimicrob Agents Chemother; 1987 Apr; 31(4):643-6. PubMed ID: 3300534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of sensitivity tests to ketoconazole. Value of experience planning in the choice of a medium].
    Mary C; Blancard A; Goudard M; Quilici M; Regli P
    Ann Biol Clin (Paris); 1987; 45(6):680-4. PubMed ID: 3326440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of fluconazole (UK-49,858) and ketoconazole on mouse lymphocyte proliferation and on Candida blastospore destruction by human polymorphonuclear leukocytes.
    Senior DS; Shaw JT
    Int J Immunopharmacol; 1988; 10(2):169-73. PubMed ID: 2836326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serotype, sensitivity to ketoconazole and inhibition of pseudomycelial growth in Candida albicans.
    Auger P; Péloquin S; Joly J; Montplaisir S; Marquis G
    Mykosen; 1984 Oct; 27(10):498-505. PubMed ID: 6096709
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced antifungal activity of ketoconazole by Euphorbia characias latex against Candida albicans.
    Giordani R; Trebaux J; Masi M; Regli P
    J Ethnopharmacol; 2001 Nov; 78(1):1-5. PubMed ID: 11585681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leucocytes in vitro.
    Cockayne A; Odds FC
    J Gen Microbiol; 1984 Mar; 130(3):465-71. PubMed ID: 6327882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.